Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.40
Bid: 102.20
Ask: 102.40
Change: -2.20 (-2.10%)
Spread: 0.20 (0.196%)
Open: 102.80
High: 102.80
Low: 102.40
Prev. Close: 104.60
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and EGM

26 Oct 2023 11:20

RNS Number : 4269R
Hipgnosis Songs Fund Limited
26 October 2023
 

LEI: 213800XJIPNDVKXMOC11Information disclosed in accordance with LR 9.6.18

Hipgnosis Songs Fund Limited("Hipgnosis" or the "Company")

Results of Annual General Meeting and Extraordinary General Meeting

 

26 October 2023

 

The Board of Hipgnosis Songs Fund Limited announces that, at the Fifth Annual General Meeting of the Company (the "AGM") held at 10.00 on 26 October 2023, Ordinary Resolutions 1, 2, 3, 4, 7, 9, 10 and 11 were passed without amendment by the requisite majority and Special Resolutions 13 and 14 were also passed without amendment by the requisite majority. Ordinary Resolutions 5 and 12 were not passed. Ordinary Resolutions 6 and 8 were withdrawn ahead of the AGM.

The Board of the Company also announces that, at an Extraordinary General Meeting of the Company (the "EGM") held at 10.30 on 26 October 2023, Ordinary Resolution 1 was not passed.

As a result of Resolution 12 (the "Continuation Resolution") not passing the Board will, in accordance with the Company's Prospectus, put forward proposals for the reconstruction, reorganisation or winding-up of the Company to Shareholders for their approval within six months following the date of today's AGM. These proposals may or may not involve winding-up the Company or liquidating all or part of the Company's existing portfolio of investments.

Due to Resolution 1 at the EGM not passing, the proposed sale of 29 music catalogues to Hipgnosis Songs Capital will not proceed.

On 28 September the Board announced Andrew Sutch's intention to step down as Chair and retire as a Director of the Company. As a result of Resolution 5 not passing at the AGM, Andrew Sutch ceased being a Director and Chair of the Board from the conclusion of the AGM. The Board is at an advanced stage of an expedited process to appoint a new Chair.

Sylvia Coleman, Senior Independent Director of Hipgnosis Songs Fund, said:

"The Board and the Investment Adviser have each engaged widely with investors over recent months. While shareholders have not supported our proposed transaction or the continuation vote, it is clear that they share our belief in the inherent quality and potential of these assets. The Directors are now expediting the appointment of a new Chair who will drive the Strategic Review we have already announced, with a clear focus on delivering improved shareholder value."

The full results of votes cast at the Annual General Meeting will shortly be made available on the Company's website at www.hipgnosissongs.com/song-investors/results-centre/

The full text of the resolutions can be found in the Notice of Annual General Meeting which is available for viewing on the website of the National Storage Mechanism which is available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at www.hipgnosissongs.com/song-investors/results-centre/

 

 

 

For further information please contact:

For Hipgnosis Songs Fund

Sylvia Coleman

Rufina Pavry (Investor Relations)

 

+44 (0) 20 4542 1530

Headland Consultancy - Financial PR to Hipgnosis Songs Fund

Susanna Voyle / Del Jones / Charlie Twigg

+44 (0) 20 3805 4822

J.P. Morgan Cazenove - Sponsor, Financial Adviser and Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

+44 (0) 20 3493 8000

Singer Capital Markets - Corporate Broker

James Moat / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0) 20 7496 3000

RBC Capital Markets - Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

 

+44 (0) 20 7635 4000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUNARROWURUAA
Date   Source Headline
19th Apr 202411:20 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
19th Apr 202410:38 amRNSForm 8.5 (EPT/RI)
19th Apr 202410:38 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 20243:40 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 20241:17 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 202411:14 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 202410:26 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 20247:00 amRNSRECOMMENDED CASH OFFER FOR HIPGNOSIS
15th Apr 20247:00 amRNSChange to Director roles and responsibilities
28th Mar 20249:02 amRNSFinal Due Diligence Findings
18th Mar 20247:00 amRNSAmendment to Operative Net Asset Value
4th Mar 20249:27 amRNSUpdate on Due Diligence, Valuation and NAV
4th Mar 20247:00 amRNSUpdate on Due Diligence, Valuation and NAV
26th Feb 20247:00 amRNSLitigation update
19th Feb 20247:00 amRNSLitigation Update
7th Feb 202412:35 pmRNSResult of Extraordinary General Meeting (“EGM”)
5th Feb 20247:00 amRNSLitigation Update
23rd Jan 20247:00 amRNSPublication of Circular/Update to Strategic Review
18th Jan 20247:00 amRNSProposed Change to Articles of the Company
11th Jan 20247:00 amRNSDirectorate Change
4th Jan 20243:26 pmRNSHolding(s) in Company
21st Dec 20237:00 amRNSInterim results to 30 September 2023
20th Dec 20237:00 amRNSChange of Auditor
19th Dec 20237:00 amRNSDelay to publication of interim results
15th Dec 20237:00 amRNSDirectorate Change
11th Dec 20237:00 amRNSAsset sale, adviser appointment, notice of results
28th Nov 202312:52 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSStrategic Review and Company Update
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSDirectorate Changes
6th Nov 20237:00 amRNSUpdate on dividend intentions
26th Oct 202311:20 amRNSResult of AGM and EGM
25th Oct 20234:00 pmRNSDirectorate Changes, withdrawal of AGM Resolutions
24th Oct 20237:00 amRNSConclusion of Go-Shop process
19th Oct 20237:00 amRNSInitiation of Strategic Review, update on RCF
17th Oct 202312:22 pmRNSHolding(s) in Company
17th Oct 202312:21 pmRNSHolding(s) in Company
17th Oct 202312:18 pmRNSHolding(s) in Company
16th Oct 20236:17 pmRNSUpdate on CRB III and dividend payment
16th Oct 20237:13 amRNSUpdate on CRB III impact and dividend payment
28th Sep 202311:07 amRNSPublication of Circular and Notice of AGM & EGM
25th Sep 20232:41 pmRNSHolding(s) in Company
22nd Sep 202310:49 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSDividend Declaration
20th Sep 20237:00 amRNSHolding(s) in Company
14th Sep 20237:00 amRNSAsset sales to fund buy backs and reduce debt
14th Aug 202312:29 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.